• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Cancer Immunotherapy

Cancer Immunotherapy

A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
Tech

British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company

By Crypto Correspondent
June 15, 2021
Photo of CytoSeek CEO Carolyn Porter
Tech

New venture fund backs CytoSeek, a startup looking to give “superpowers” to cancer-fighting T-cells

By Crypto Correspondent
March 16, 2021
Photo of U.S. Speaker of the House Nancy Pelosi wearing a mask and gesturing with her hands.
Health

A Pelosi snub and a giant federal COVID grant: Another dizzying day in Washington for the U.K.’s AstraZeneca

By Financial Writer
October 12, 2020
A sign is seen at an AstraZeneca site in Macclesfield
Health

Here’s Why Shares in This Former Pfizer Target Are Tanking

By Research Team
July 27, 2017
Going to the Wall Against Cancer and Apathy: FDR, Obama, Trump, Laver, and Kyrgios
Commentary

Going to the Wall Against Cancer and Apathy: FDR, Obama, Trump, Laver, and Kyrgios

By Paul Sanderson and Bethany Cianciolo
July 13, 2017
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
Health

Why Shares of Next-Gen Cancer Biotech Juno Rallied Today

By Trading Desk
July 14, 2016
Stocks Continue Downward Slide On Heels Of Yesterday's Extreme Fall
Health

This Fund Wants to Make It Easier to Invest in Biotech Stocks

By Research Team
June 15, 2016
Bristol Myers Yervoy Cancer Drug
Health

FDA Has Strong Words for Cancer Drug Developers

By News Correspondent
June 10, 2016
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
Health

Merck CEO: We’re on the Hunt for Deals in 2016

By Market Analyst
May 6, 2016
Napster co-founder, Sean Parker, General
Health

Sean Parker Launches an Unprecedented Cancer Research Effort

By Blockchain Reporter
April 13, 2016

Most Popular

  • AI
    Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
    By Investment Desk
  • Big Tech
    Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
    By Contributing Writer
  • Travel & Leisure
    Transportation chief offers advice to increasingly angry Americans: ‘Let’s maybe go back to an era where we didn’t wear...
    By Research Team
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.